ImaRx Postpones Release of First Quarter 2008 Financial Results
May 13 2008 - 4:50PM
PR Newswire (US)
Live Webcast and Conference Call Scheduled for Thursday, May 15th
at 5 PM ET TUCSON, Ariz., May 13 /PRNewswire-FirstCall/ -- ImaRx
Therapeutics, Inc. (NASDAQ:IMRX) today announced that the Company
has postponed its live webcast and conference call to Thursday, May
15, 2008, at 5:00 p.m. ET to discuss first quarter 2008 financial
results; this call was originally scheduled for Tuesday, May 13,
2008, at 5:00 p.m. ET. The live webcast can be accessed through
ImaRx's corporate website at http://www.imarx.com/ and will be
archived on the website for 14 days following the event. Interested
parties may access the conference call by dialing (877) 407-4018 in
the U.S. and Canada or (201) 689-8471 internationally. A telephonic
replay will be available through May 22, 2008 by dialing (877)
660-6853 in the U.S. and Canada or (201) 612-7415 internationally
(Account Number 3055 and Conference ID 284385). About ImaRx
Therapeutics ImaRx Therapeutics is a biopharmaceutical company
developing and commercializing therapies for vascular disorders.
The Company's research and development efforts are focused on
therapies for stroke and other vascular disorders using its
proprietary microbubble technology. The Company's commercialization
efforts are currently focused on its product, urokinase, for the
treatment of acute massive pulmonary embolism. Contacts: The Ruth
Group (Investors/Media) Sara Ephraim/Jason Rando 646-536-7002 or
7025 DATASOURCE: ImaRx Therapeutics, Inc. CONTACT: Investors, Sara
Ephraim, +1-646-536-7002, , or Media, Jason Rando, +1-646-536-7025,
, both of The Ruth Group, for ImaRx Therapeutics, Inc. Web site:
http://www.imarx.com/
Copyright
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Immuneering (NASDAQ:IMRX)
Historical Stock Chart
From Jul 2023 to Jul 2024